Skip to main content

Research Repository

Advanced Search

The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): Description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease

Khan, Fasihul; Stewart, Iain; Howard, Lucy; McKeever, Tricia; Jones, Steve; Hearson, Glenn; Braybrooke, Rebecca; Edwards, Colin; Jenkins, Gisli; Saini, Gauri

Authors

Fasihul Khan

Iain Stewart

Lucy Howard

TRICIA MCKEEVER tricia.mckeever@nottingham.ac.uk
Professor of Epidemiology and Medical Statistics

Steve Jones

Glenn Hearson

Rebecca Braybrooke

Colin Edwards

Gisli Jenkins

Gauri Saini



Abstract

Introduction: The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS) is a multicentre, prospective, observational cohort study. The aims of this study are to identify genetic, serum and other biomarkers that may identify specific molecular mechanisms, reflecting disease endotypes that are shared among patients with progressive pulmonary fibrosis regardless of aetiology. Furthermore, it is anticipated that these biomarkers will help predict fibrotic activity that may identify patterns of disease behaviour with greater accuracy than current clinical phenotyping.

Methods and analysis: 200 participants with the multidisciplinary team confirmed fibrotic lung disease (50 each of rheumatoid-interstitial lung disease (ILD), asbestosis, chronic hypersensitivity pneumonitis and unclassifiable ILD) and 50 idiopathic pulmonary fibrosis participants, recruited as positive controls, will be followed up for 2 years. Participants will have blood samples, lung function tests, quality of life questionnaires and a subgroup will be offered bronchoscopy. Participants will also be given the option of undertaking blinded home handheld spirometry for the first 3 months of the study. The primary end point will be identification of a biomarker that predicts disease progression, defined as 10% relative change in forced vital capacity (FVC) or death at 12 months.

Ethics and dissemination: The trial has received ethical approval from the National Research Ethics Committee Nottingham (18/EM/0139). All participants must provide written informed consent. The trial will be overseen by the INJUSTIS steering group that will include a patient representative, and an independent chairperson. The results from this study will be submitted for publication in peer-reviewed journals and disseminated at regional and national conferences.

Trial registration number NCT03670576

Citation

Khan, F., Stewart, I., Howard, L., McKeever, T., Jones, S., Hearson, G., …Saini, G. (2019). The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): Description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease. BMJ Open Respiratory Research, 6(1), 1-7. https://doi.org/10.1136/bmjresp-2019-000439

Journal Article Type Article
Acceptance Date Apr 26, 2019
Online Publication Date Jun 4, 2019
Publication Date Jun 4, 2019
Deposit Date May 14, 2019
Publicly Available Date Jun 25, 2019
Journal BMJ Open Respiratory Research
Electronic ISSN 2052-4439
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 6
Issue 1
Article Number e000439
Pages 1-7
DOI https://doi.org/10.1136/bmjresp-2019-000439
Public URL https://nottingham-repository.worktribe.com/output/2048335
Publisher URL https://bmjopenrespres.bmj.com/content/6/1/e000439

Files




You might also like



Downloadable Citations